Exelixis
EXEL
#1855
Rank
A$15.69 B
Marketcap
A$61.79
Share price
-0.51%
Change (1 day)
0.80%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: A$68.45 AUD on 2000-07-26

Lowest end of day price: A$1.79 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2026

Annual Stock Price Performance

Year Performance
2026 1.44%
2025 29.14%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
A$319.45 1.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$37.11 1.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$481.22 2.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$64.74 1.19%๐Ÿ‡ซ๐Ÿ‡ท France
A$151.74-1.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$84.21 5.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$72.70 1.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$0.83 6.88%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.85 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA